The United States leads global R&D health appropriations, significantly outpacing Japan and France despite a sizable increase of 26.43% in 2023. Japan's 4% growth still positions it far below the U.S. France and Russia face declining investments, with France seeing a slight drop of 2.47%. The United Kingdom's investment grew by 10.3%, indicating strong focus on health R&D. Denmark and Lithuania showed notable increases of 44.3% and 37.3% respectively, highlighting their expanding emphasis. Noteworthy is the declining trend in Norway and Australia, with reductions of 17.76% and 21.16% respectively, showing varying national priorities.
Future considerations should watch for:
- Potential strategic shifts in government priorities amidst geopolitical changes.
- Collaborative funding patterns in light of global health challenges.
- Impact of technological advancements on R&D budgets and innovation outcomes.
Top countries in Government Budget Appropriations or Outlays for R&D in Health by Country
| # | 10 Countries | Million US Dollars PPP, Constant | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 124,580 | 2023 | +3.1% | +26.43% | View data |
| 2 | 2 Japan | 45,180 | 2023 | +2.9% | +4% | View data |
| 3 | 3 France | 14,970 | 2023 | +3.24% | -2.47% | View data |
| 4 | 4 Russia | 14,670 | 2023 | -0.54% | -0.27% | View data |
| 5 | 5 Italy | 13,280 | 2023 | +2.5% | +2.26% | View data |
| 6 | 6 United Kingdom | 5,710 | 2023 | -4.34% | +10.3% | View data |
| 7 | 7 Denmark | 2,400 | 2023 | +2.85% | +44.3% | View data |
| 8 | 8 Norway | 1,240 | 2023 | -2.19% | -17.76% | View data |
| 9 | 9 Portugal | 1,230 | 2023 | +2.11% | +1.25% | View data |
| 10 | 10 Hungary | 769.42 | 2023 | +2.43% | -2.92% | View data |
